bolster top line dairi downer
ep miss consensu pahc ep
slightli estim better revenu off-set lower
profit re-affirmed guidanc point ep low end
guidanc rang vs consensu lower
ep reflect miss well slower
vaccin nutrit specialti growth experi balanc
revenu upsid profit light revenu rose well plan
surprisingli stronger anim health view
mfa acceler ou volum note strength
asia latam partial off-set domest declin nutrit spec
vs disappoint dairi headwind slower growth
poultri vaccin vs also well plan loss
domest distribut agreement partial off-set volum certain intenational
market gross margin fell bp bp plan
sg fell bp albeit bp plan drive ebitda margin
contract bp bp short view gener million
cash cash reserv stand million
share may ebb share may subsid on-going deterior
key growth higher margin segment vaccin nutrit
spec continu call ep lower end rang
take necessari step diversifi view benefit
invest materi nt encourag strength
ou impli stabil across highli regul categori remain
cautiou weak domest mfa vaccin nutrit spec
call commentari focu demand trade dynam swine exposur
china asf fx new develop efforts/cost share current
trade ep justifi discount diversifi industri
leader risk shift regulatori demand environ
valuat metric
number share
price month
 close
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
lead manufactur anim health product
concentr product anim product prevent control
treat diseas enhanc health nutrit overal
product livestock
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
challeng relat antibiot use greater expect ramp
faster-grow subsector anim health vaccin nutrit
specialti favor epidemiolog weather
macroeconom trend influenc underli util trend
consider pick us intern livestock
grey sky valuat assum harsher expect
regulatori challeng global use antibiot medicin feed
addit weak global livestock demand
 close
latest revenu strength encourag continu beat mfa though
miss sale trend across faster-grow profit sub-seg vaccin
nutrit specialti repres anoth strong quarter revenu
sub-seg experienc declin throughout vfd-relat headwind
notabl sale vaccin decreas poor dairi fundament continu
weigh nutrit specialti contribut putrid growth quarter well
plan
importantli ep guidanc match estim consensu
howev management recapitul lower end rang like
note management state major line item like lower end
guidanc rang wherea management call revenu ebitda
lower end respect rang remind announc
enter agreement develop canin lyme diseas vaccin notabl entranc
faster-grow companion anim speci segment consequ incur
increment cost associ effort along potenti develop effort
partnership focus nutrit vaccin segment across product
companion anim speci group compani target contribut
effort materi longer term next month make hard-hit
catalyst longer term natur
figur quarterli revenu growth segment
anim health revenu
s/other revenu segment revenu increas well
ahead estim addit penetr intern particularli
asia pacif latin america region
nutrit specialti revenu growth nutrit specialti
well plan continu pressur across dairi segment
vaccin revenu vaccin sale decreas vs estimate due
unstabl econom condit intern loss domest distribut
agreement partial off-set volum growth intern market
miner nutrit revenu
miner nutrit revenu consist view vs estimate driven
higher averag sell price increas volum miner nutrit least profit
busi expect meaning growth driver extend
histori busi industry-lead presenc extens relationship across
suppli chain help unlock cross sell opportun broader anim health
perform product revenu
perform product revenu growth impress vs estimate volum
growth copper-bas person care product divest portion
perform product busi past sever year expect continu
deemphas segment opportunist divestitur go forward profit
within segment remain rel low ebitda margin greater
focu higher margin anim health busi bode well profit profil
quarter gener million cash cash reserv stand
million capit deploy strategi remain focus de-lever dividend
tuck-in acquisit partnership supplement growth
expect revenu growth reflect growth anim health
miner nutrit perform product ebitda margin
bp lower due aforement increment invest lower revenu
view along rel flat interest tax expens pursuant tax reform
drive ep growth
expect ep grow revenu growth
assum rel stabl fundament across us livestock industri build
momentum cross-market intern strategi forecast ebitda
margin expans bp better product mix oper effici
ep current trade discount histor averag
view justifi due slower growth profil price target
base multipl ep
compani mention price
